menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Advances in Treatment of Moderate to Severe Psoriasis

This enduring audio activity includes an interview with two expert dermatology faculty who will discuss advances in the understanding of psoriasis ...

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This enduring audio activity includes an interview with two expert dermatology faculty who will discuss advances in the understanding of psoriasis pathogenesis as well as the practical considerations of switching, escalating, and adjusting therapy in patients with moderate to severe psoriasis.

  • Disclosure of Conflicts of Interest

    Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below.

    *The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

    The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity:

    • Planners (Forefront Collaborative): Miranda Armie; Marianna Shershneva

    The following individuals have disclosed that they and/or their spouse/partner has had a financial relationship in the past 12 months:

    • Faculty: Linda Stein Gold; speaker, advisor, and researcher for Celgene, Leo Pharma, Novartis, Taro, and Valeant; consultant and researcher for GSK
    • Faculty: Neil J. Korman: advisor for AbbVie, Celgene, Eli Lilly, Janssen, Regeneron, Sun Pharma, and Valeant; speaker for AbbVie, Celgene, Eli Lilly, Janssen, and Novartis; investigator for Eli Lilly, Merck, Pfizer, Prothena, and Regeneron; consultant for Novartis and Pfizer

    CME Content Review
    The content of this activity was independently peer reviewed. The reviewers of this activity have no relevant financial relationships to disclose.

  • Target Audience

    The target audience for this educational activity is dermatologists. Other healthcare professionals, including rheumatologists, physician assistants, and nurse practitioners who treat patients with psoriasis, may benefit from participation in this activity.

  • Learning Objectives

    As a result of participation in this educational activity, participants should be able to:

    • Explain advances in the understanding of psoriasis pathogenesis that inform the development of increasingly efficacious treatments for moderate to severe psoriasis.
    • Discuss therapeutic approaches and appropriate monitoring of therapeutic outcomes in patients with psoriasis and comorbidities.
  • Accreditation and Credit Designation Statements

    Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation for Enduring
    Forefront Collaborative designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

  • Terms of Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. Forefront Collaborative does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Forefront Collaborative. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Trade names of drugs are used for identification purposes only and do not imply endorsement. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ReachMD you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.